Flow Traders U.S.
BIB icon

Flow Traders U.S.’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Flow Traders U.S.’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-100
Closed -$5K – 503
2016
Q3 		$5K Buy
+100
New +$4.75K ﹤0.01% 357
2014
Q4 		– Sell
-12,730
Closed -$662K – 184
2014
Q3 		$662K Buy
12,730
+6,242
+96% +$302K 0.08% 78
2014
Q2 		$301K Buy
+6,488
New +$256K 0.06% 79

Other funds holding BIB

RIA
RPG Investment Advisory Pleasanton, California $540M AUM 37.68% 1-Year Est. Return
Opus Point Partners Management
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Chase Investment Counsel
Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return
BA
BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Timber Hill
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Virtu KCG Holdings
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Flow Traders U.S.'s BIB Position: Q4 2016 in Review

Flow Traders U.S. sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2016, closing a stake of 100 shares — an estimated $5K sold.

Flow Traders U.S. first reported a position in BIB in Q2 2014 and held it in 3 quarters. The position peaked at $662K in Q3 2014. 31 funds tracked by Wall St. Rank hold BIB as of Q4 2016.

  • Flow Traders U.S. reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2016 after selling out during the quarter.
  • Flow Traders U.S. sold 100 ProShares Ultra NASDAQ Biotechnology shares in Q4 2016, an estimated $5K.
  • Flow Traders U.S. first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2014 and held it in 3 quarters.
  • Flow Traders U.S.'s ProShares Ultra NASDAQ Biotechnology position peaked at $662K in Q3 2014.
  • 31 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2016.

Based on Flow Traders U.S.'s 13F filing for Q4 2016, filed 14 Feb 2017.